Fed. Circ. Revives Astellas Patent Axed As Natural Law

By Ryan Davis · September 18, 2024, 9:29 PM EDT

The Federal Circuit on Wednesday vacated a lower court's invalidation of an Astellas Pharma overactive bladder medication patent for claiming only a natural law, saying the holding was improper because the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Astellas Pharma, Inc. v. Sandoz Inc.

Case Number

23-2032

Court

Appellate - Federal Circuit

Nature of Suit

835 Patent - (ANDA) (Fed. Qst.)

Date Filed

June 16, 2023